Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2002 Aug;95(8):391-7.
doi: 10.1177/014107680209500804.

Targeting the renin-angiotensin system in patients with renal disease

Mark A J Devonald  1 , Fiona E Karet
Affiliations
Review

Targeting the renin-angiotensin system in patients with renal disease

Mark A J Devonald et al. J R Soc Med. 2002 Aug.
No abstract available

PubMed Disclaimer

Figures

<i>Figure 1</i>
Figure 1
Schematic representation of renin-angiotensin-aldosterone. Agents providing pharmacological blockade are shown in italics. ACEI-angiotensin converting-enzyme inhibitor; ARB=angiotensin II receptor blocker; NSAID=non-steroidal anti-inflammatory drug; AI=angiotensin I; AII=angiotensin II; AT1 and AT2=type 1 and type 2 angiotensin II receptors respectively
<i>Figure 2</i>
Figure 2
Possible treatment algorithm for patients with proteinuria. See text for explanation of target BPs. Broken arrows indicate points of particular caution. ACEI=angiotensin converting-enzyme inhibitor; ARB=angiotensin II receptor blocker; RAS=renal artery stenosis
See this image and copyright information in PMC

References

    1. Parving HH, Andersen AR, Smidt UM, et al. Early aggressive antihypertensive treatment reduces rate of decline in kidney function in diabetic nephropathy. Lancet 1983;i: 1175-9 - PubMed
    1. Hovind P, Rossing P, Tarnow L, et al. Remission and regression in the nephropathy of type 1 diabetes when blood pressure is controlled aggressively. Kidney Int 2001;60: 277-83 - PubMed
    1. UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ 1998;317: 703-13 - PMC - PubMed
    1. Petersen JC, Adler S, Burkart JM, et al. Blood pressure control, proteinuria, and the progression of renal disease: the Modification of Diet in Renal Disease Study. Ann Intern Med 1995;123: 754-62 - PubMed
    1. Remuzzi G, Ruggenenti P, Benigni A. Understanding the nature of renal disease progression. Kidney Int 1997;51: 2-15 - PubMed

MeSH terms

Substances